analysis
LONDON – Cordel Group PLC (AIM: CRDL) has received a Certificate of Approval from Network Rail for its Artificial Intelligence (AI) platform, which analyzes transport corridors. The certification endorses Cordel’s AI-powered outputs for measuring Overhead Line Equipment (OLE) on electrified railways using LiDAR data collected from passenger trains traveling at…
Oracle (NYSE:) is at a critical juncture as it navigates the evolving AI landscape. The company’s strategic positioning within the AI infrastructure market will significantly influence its future growth. With a year-to-date performance outpacing many of its peers, Oracle’s stock is up 23%, driven by its strong positioning in the…
Affiliate links for the products on this page are from partners that compensate us (see our advertiser disclosure with our list of partners for more details). However, our opinions are our own. See how we rate student loans to write unbiased product reviews. Business Insider’s personal finance team compared Funding…
By Chad Terhune (Reuters) -Only one in four U.S. patients prescribed Novo Nordisk’s Wegovy or Ozempic for weight loss were still taking the popular medications two years later, according to an analysis of U.S. pharmacy claims provided to Reuters that also showed a steady decline in use over time. The…
President Joe Biden is running for re-election, and his potential second term could significantly impact various sectors, including energy. Understanding the implications of Biden 2.0 on energy stocks is crucial for investors, given the administration’s strong focus on climate change, renewable energy, and regulatory changes. Biden’s energy policies starkly contrast…
Goldman Sachs (NYSE:) has analyzed NTPC’s fourth-quarter performance for FY24, noting an adjusted consolidated profit after tax (PAT) of Rs 53 billion, slightly below the estimated INR 55 billion. This shortfall was due to higher-than-expected fixed cost under-recovery from operational issues at the Barh and Barauni power plants.NTPC’s renewable energy…
By Maggie Fick LONDON (Reuters) – Novo Nordisk (NYSE:)’s Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight and obese people in a large study, according to a new analysis the Danish drugmaker published on Saturday. The analysis, from a large study for which substantial results had been…
By Xie Yu and Scott Murdoch HONG KONG/SYDNEY (Reuters) – Country Garden has hired Kroll to carry out a liquidation analysis ahead of a court hearing in mid-May, according to three sources, as the embattled Chinese developer pushes ahead with its offshore debt restructuring plan. China’s biggest private developer is…
